Consistent with previous research, our results indicated ivermectin inhibited the growth of ESCC cells by regulating the NF-κB signaling pathway-mediated apoptosis, at least in part, mediated by regulation of Bax and Bcl-2 expression. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.